Advanced MR Technique for the Prediction of a Complete Response Following Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Comparative Study Between DWI b2000 and b1000
Open Access
- 21 October 2026
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (10) , 537
Abstract
Background/Objectives: From the viewpoint of personalized medicine, it is important to properly select patients with a complete response (CR) after neoadjuvant chemoradiotherapy (nCRT) because they are candidates for “watch-and-wait” management in locally advanced rectal cancer (LARC). The aims of this study were to evaluate the added value of diffusion-weighted imaging (DWI) b2000 to high-resolution T2-weighted images (HR-T2WI) and to compare the diagnostic performance of DWI b2000 and b1000 for assessing a CR in patients with LARC after nCRT. Methods: This retrospective study included 55 patients (male: 40, female: 15; mean age: 60.1) who underwent pre- and post-nCRT 3T MRI, including DWIb1000 and DWIb2000. Two blinded radiologists independently assessed the likelihood of a CR using a five-point scale across three image sets: T2-weighted images (T2WI), T2WI + DWIb1000, and T2WI + DWIb2000. T2WI were provided because DWI is not used as a standalone sequence in clinical practice when evaluating the therapeutic response to nCRT. A crossover review of DWIb1000 and DWIb2000 with a four-week interval was used to minimize recall bias. The reference standard of a CR was histopathologic examination or clinical remission in cases of watch-and-wait management. For each reader, diagnostic performance was compared across three image sets using pairwise comparisons of the receiver operating characteristic (ROC) curves. Results: The study population comprised 19 patients with a CR and 36 patients with residual tumor. For both readers, adding DWIb2000 significantly enhanced diagnostic performance compared to T2WI alone (AUC for reader 1: 0.918, 0.806, p = 0.0288; AUC for reader 2: 0.868, 0.768, p = 0.0414, respectively), likewise, DWIb1000 (for reader 1: 0.955, p = 0.0015; for reader 2: 0.863, p = 0.0162). However, no significant difference in diagnostic performance was found between DWIb1000 and DWIb2000 for each reader (for reader 1: p = 0.0931; for reader 2: p = 0.8936). Conclusions: Adding DWIb2000 to T2WI improved diagnostic performance for identifying a CR after nCRT compared to T2WI alone. No statistical difference was detected between DWIb1000 and DWIb2000.Keywords
This publication has 36 references indexed in Scilit:
- Diffusion-weighted imaging in rectal cancer MRI from theory to practiceAbdominal Radiology, 2025
- Ultra-high b-value DWI in rectal cancer: image quality assessment and regional lymph node prediction based on radiomicsEuropean Radiology, 2024
- Evolution of therapy for locally advanced rectal cancerJournal of Surgical Oncology, 2023
- The optimized rectal cancer MRI protocol: choosing the right sequences, sequence parameters, and preparatory strategiesAbdominal Radiology, 2023
- Rectal cancer with complete endoscopic response after neoadjuvant therapy: what is the meaning of a positive MRI?European Radiology, 2021
- Diagnostic accuracy of b800 and b1500 DWI-MRI of the pelvis to detect residual rectal adenocarcinoma: a multi-reader studyAbdominal Radiology, 2020
- Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancerAbdominal Radiology, 2019
- Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teachingEuropean Radiology, 2017
- Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?European Radiology, 2013
- What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?European Radiology, 2011